AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Letshe 2.5 Tablet

Prescription Icon
Prescription Required

Marketer

Horus Life Sciences

Salt Composition

Letrozole (2.5mg)

Overview Letshe 2.5 Tablet

Postmenopausal women with breast cancer may find relief with Letshe 2.5mg tablets. This medication can be a standalone treatment or used alongside procedures like surgery or radiation therapy. In advanced cases, it helps curb the cancer's spread. Letshe 2.5mg tablets can be ingested with or without food, always following your doctor's prescribed dosage and regimen for optimal results. Dosage varies depending on individual needs and the doctor will tailor the treatment plan accordingly. Continuous use is vital as directed. Common side effects include sweating, tiredness, hot flushes, and elevated cholesterol. Report any concerning side effects to your physician, who can offer management strategies. Prior to commencing treatment, inform your doctor about any pre-existing liver or kidney conditions, osteoporosis, or other medications you're currently using, as interactions are possible. Furthermore, disclose any pregnancy or breastfeeding plans. Your doctor may order blood tests to monitor vitamin D levels and bone density throughout the treatment.

Primary Ingredients of Letshe 2.5 Tablet

No text was provided to rewrite.

Uses of Letshe 2.5 Tablet

Managing breast cancer

Major Benefits of Letshe 2.5 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letshe 2.5mg tablets can be consumed with or without food, however, consistent timing is recommended.

Common Side effects of Letshe 2.5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letshe 2.5 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letshe 2.5 Tablets can be administered with or without food, though consistent timing is recommended.

How Letshe 2.5 Tablet works:

Estrogen production is reduced by Letshe 2.5 Tablet, an aromatase inhibitor. This medication's mechanism of action involves lowering the body's estrogen levels, thereby potentially inhibiting or slowing the growth of estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with the concomitant use of Letshe 2.5 Tablet and alcohol.

PregnancyPregnancyUNSAFE

The use of Letshe 2.5 Tablet is strongly contraindicated during pregnancy. Pregnant individuals should consult a physician before use, given that research in both animal and human studies has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingUNSAFE

Administering Letshe 2.5 Tablet while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Taking Letshe 2.5 Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

For individuals with kidney disease, Letshe 2.5 Tablet is considered safe, and no dosage modification is typically necessary. Nevertheless, data on its use in patients with end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Letshe 2.5 Tablets. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Letshe 2.5 Tablet :

Should you forget a Letshe 2.5 Tablet dose, take it promptly. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Letshe 2.5 Tablet

LabelValue
Chemical Type Diphenylmethane derivative
Developing Habits No.
Type of Therapy Cancer Treatments

FAQs on Letshe 2.5 Tablet

LetShe 2.5 Tablets are an aromatase inhibitor, typically prescribed for postmenopausal women with breast cancer, including those who have undergone surgery or chemotherapy.
LetShe 2.5 tablets are anti-estrogen medications. They work by inhibiting aromatase, an enzyme that produces estrogen. This reduces estrogen levels, which can help prevent the growth of estrogen-dependent breast cancers.
For advanced breast cancer or cancer that has spread, continue Letshe 2.5 Tablet until tumor progression. Following tamoxifen or surgery, take Letshe 2.5 Tablet for five years or until recurrence, whichever occurs first. Alternatively, a sequential treatment of two years of Letshe 2.5 Tablet followed by three years of tamoxifen may be used.
While irbesartan and Letshe 2.5 Tablet can be taken together, monitor your blood pressure closely as Letshe 2.5 Tablet may raise it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letshe 2.5 Tablet may lead to cataracts. Report blurred vision or eye irritation to your doctor promptly.
Letshe 2.5 Tablet may cause hot flushes, a common side effect resulting from decreased estrogen. These typically lessen as your body adapts to the medication. However, some experience hot flushes throughout treatment, subsiding months afterward. Severe discomfort warrants a consultation with your doctor for appropriate management.
Letshe 2.5 Tablet may rarely cause serious side effects, including stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letse 2.5 Tablet can reduce bone density (osteoporosis) by lowering estrogen levels. Your doctor might monitor your bone density with tests before, during, and after treatment.
The Ministry of Health and Family Welfare restricts Letshe 2.5 Tablet use to ovulation induction in women with anovulatory infertility.
Letshe 2.5 Tablet
112
MRP 130
13% off